<DOC>
	<DOCNO>NCT01901120</DOCNO>
	<brief_summary>This study evaluate safety efficacy long-term use Betanis ( generic name : mirabegron ) , determine adherence treatment mirabegron .</brief_summary>
	<brief_title>Long-Term Specified Drug Use-results Survey Betanis Tablets</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Mirabegron</mesh_term>
	<criteria>Patients administer mirabegron treatment urinary urgency , daytime frequency , urgency incontinence associate overactive bladder also treatment history mirabegron .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>BetanisÂ®</keyword>
	<keyword>mirabegron</keyword>
	<keyword>Overactive Bladder</keyword>
</DOC>